Gilbert, AZ5 Active Studies

Osteogenesis Imperfecta Clinical Trials in Gilbert, AZ

Find 5 actively recruiting osteogenesis imperfecta clinical trials in Gilbert, AZ. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
878
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Gilbert

RecruitingGilbert, AZNCT05429632

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

This is a multi-center, randomized, double-blinded, placebo controlled trial....

366 participants
Priothera SAS
View Study Details
RecruitingGilbert, AZNCT04067336

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

In this trial, ziftomenib, a menin-MLL(KMT2A) inhibitor, will be tested in patients for the first time. The trial includes a Main Study and four sub-studies. In the Main Study (including Phase 1a, Pha...

263 participants
Kura Oncology, Inc.
View Study Details
RecruitingGilbert, AZNCT06384261

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

The goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to v...

120 participants
OncoVerity, Inc.
View Study Details
RecruitingGilbert, AZNCT04358393

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

This is a two Part study in patients with relapsed/refractory acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), or high risk myelodysplastic syndrome (MDS) that will initially eval...

69 participants
Ascentage Pharma Group Inc.
View Study Details
RecruitingGilbert, AZNCT06621251

Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection

TRL1068 is expected to eliminate the pathogen-protecting biofilm in the prosthetic joint and surrounding tissue, thus making pathogens substantially more susceptible to established antibiotic treatmen...

60 participants
Trellis Bioscience LLC
View Study Details

About Osteogenesis Imperfecta Clinical Trials in Gilbert

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 5 osteogenesis imperfecta clinical trials recruiting participants in Gilbert, AZ. These studies are seeking a combined 878 participants. Research is being sponsored by Priothera SAS, Kura Oncology, Inc., OncoVerity, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Gilbert — FAQ

Are there osteogenesis imperfecta clinical trials in Gilbert?

Yes, there are 5 osteogenesis imperfecta clinical trials currently recruiting in Gilbert, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gilbert?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you about next steps.

Are clinical trials in Gilbert free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gilbert studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 5 active trials in Gilbert are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated March 2, 2026 from ClinicalTrials.gov